
Orion Oyj
HEL:ORNBV.HE
Overview | Financials
Company Name | Orion Oyj |
Symbol | ORNBV.HE |
Currency | EUR |
Price | 37.63 |
Market Cap | 5,281,746,499 |
Dividend Yield | 2.15% |
52-week-range | 32.89 - 55.16 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Dr. Liisa Hurme |
Website | https://www.orion.fi |
An error occurred while fetching data.
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD